IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)Research in Context

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)Research in Context

Background: Certain immunoglobulins (Ig) are proposed to have protective functions in atherosclerosis. Objectives: We tested whether serum levels of IgG and IgM autoantibodies against malondialdehyde low density lipoprotein (MDA-LDL) are associated with clinical coronary heart disease (CHD) and unfa...

Full description

Bibliographic Details
Main Authors: Victor J. van den Berg, Dorian O. Haskard, Artur Fedorowski, Adam Hartley, Isabella Kardys, Mikhail Caga-Anan, K. Martijn Akkerhuis, Rohit M. Oemrawsingh, Robert Jan van Geuns, Peter de Jaegere, Nicolas van Mieghem, Evelyn Regar, Jurgen M.R. Ligthart, Victor A.W.M. Umans, Patrick W. Serruys, Olle Melander, Eric Boersma, Ramzi Y. Khamis
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396418303098

Internet

http://www.sciencedirect.com/science/article/pii/S2352396418303098

Similar Items